Pharmacodynamics General Dapagliflozin Increases in the amount of glucose excreted in the urine were observed in healthy subjects and in patients with type 2 diabetes mellitus following the administration of dapagliflozin (see Figure 1)
Angiotensin-converting enzyme inhibitor use and major cardiovascular outcomes in type 2 diabetes mellitus treated with the dipeptidyl peptidase 4 inhibitor alogliptin
Consider B-complex for energy, vitamin D if deficient, and omega-3 for heart health
..or else the weight comes back
Some patients may ask about switching from semaglutide to tirzepatide if weight loss slows, side effects become difficult, blood sugar goals change, or they are not seeing the desired response
Our professional healthcare providers can evaluate your health status and determine if semaglutide GLP-1 is right for you, considering your weight loss goals and overall health